|
|
|
Welcome to the Quality Counts. For those health conscious consumers and medical professionals that are looking to purchase nutritional supplements, vitamins, herbs, learning about medications, losing weight, health food, low carbs, high protein nutrition, and exercise, you have come to the right place. Quality Counts serves both the medical practitioner and consumer interested in nutritional therapy and alternative medicine.
Home > Anti-aging Research > Zyflamend
Zyflamend
Specific Recommendation:
News and Research:
- Herbal
extract may treat prostate cancer - MSNBC, 11/27/05 -
"Zyflamend has the ability, in culture
at least, to reduce prostate cancer cell growth by as much as 78 percent and
induce cancer cell death or “apoptosis,”"
-
Herbal COX Inhibitor Acts Against Prostate Cancer Cells - Medscape,
11/25/05
-
Columbia Study Suggests Benefits Of Herbal Extract In Early Treatment Of
Prostate Cancer - Science Daily, 11/13/05 -
"Zyflamend®, a unique herbal extract
preparation, suppresses the growth of prostate cancer cells and induces
prostate cancer cells to self-destruct via a process called “apoptosis"
- Herb Mix Nixes Prostate Cancer in Lab - WebMD, 12/13/02 -
"A number of recent studies point to COX-2 as an important factor in cancer-cell growth. In the Columbia studies, Zyflamend decreased
COX-2 activity about as well as a potent COX-2-inhibiting drug ... The herbal mix is called Zyflamend, from New Chapter Inc., and has 10 herbs: holy basil, turmeric, ginger, green tea, rosemary, hu zhang, Chinese goldthread,
barberry, oregano, and Scutellaria biacalensis"
Abstracts:
-
Zyflamend, a polyherbal preparation, inhibits invasion, suppresses
osteoclastogenesis, and potentiates apoptosis through
down-regulation of NF-kappa B activation and NF-kappa B-regulated
gene products - Nutr Cancer. 2007;57(1):78-87 -
"Zyflamend inhibited receptor activator of
NF-kappa B ligand-induced osteoclastogenesis, suppressed tumor
necrosis factor (TNF)-induced invasion, and potentiated the
cytotoxicity induced by TNF and chemotherapeutic agents, all of
which are known to require NF-kappa B activation. Zyflamend
suppressed NF-kappa B activation induced by both TNF and cigarette
smoke condensate. The expression of NF-kappa B-regulated gene
products involved in antiapoptosis (inhibitor-of-apoptosis protein
1/2, Bcl-2, Bcl-xL, FADD-like interleukin-1betaconverting
enzyme/caspase-8 inhibitory protein, TNF receptor-associated
factor-1, and survivin) and angiogenesis (vascular endothelial
growth factor, cyclooxygenase-2, intercellular adhesion molecule,
and matrix metalloproteinase-9) was also down-regulated by
Zyflamend. This correlated with potentiation of cell death induced
by TNF and chemotherapeutic agents. Overall, our results indicate
that Zyflamend suppresses osteoclastogenesis, inhibits invasion, and
potentiates cytotoxicity through down-regulation of NF-kappa B
activation and NF-kappa B-regulated gene products" - See
Zyflamend products at iHerb
.
Related Searches:
70516
|